The Contextualizer is eligible to "contextualize"
the market relationships of Aprogen pharmaceuticals,Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices,
fabrics and competitors around the globe.
Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.
The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.
The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.
The table is especially crucial if Palmy did (yet) not find any location to map the competitor to. Note that "medium accuracy" implies that the value must be noticed with care, because it may be a subsidiary instead of a competitor.
Competitor | Private? | Source | Accuracy | Country | City |
---|---|---|---|---|---|
Dongbu Corporation | FMP | High | South Korea | Seoul | |
Bukwang Pharmaceutical Co., Ltd. | FMP | High | South Korea | Seoul | |
Mirae Corporation | FMP | High | South Korea | Cheonan-si | |
Yungjin Pharm. Co., Ltd. | FMP | High | South Korea | Seoul | |
Dong\u002DA Socio Holdings Co., Ltd. | FMP | High | South Korea | Seoul |
The table is especially crucial if Palmy did (yet) not find any location to map the subsidiary to. All subsidiaries are sourced from exhibits of the SEC (21.1).
Subsidiary | Private? | Country | City |
---|---|---|---|
- | - | - | - |